✦ LIBER ✦

Conceptual aspects of combining rituximab and Campath-1H in the treatment of chronic lymphocytic leukemia

✍ Scribed by Chadi Nabhan; Steven T Rosen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alemtuzumab (Campath-1H) in the treatmen

✍ Alinari, L; Lapalombella, R; Andritsos, L; Baiocchi, R A; Lin, T S; Byrd, J C 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 146 KB

Treatment of refractory chronic lymphocy

✍ Ulrike Heider; Claudia Fleissner; Ivana Zavrski; Christian Jakob; Toralf Dietzel 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

CAMPATH (alemtuzumab) for the treatment

✍ Dumont, Francis J 📂 Article 📅 2002 🏛 Expert Reviews 🌐 English ⚖ 228 KB

Clinical effects of alemtuzumab (Campath

✍ Anders Osterborg; Hakan Mellstedt; Michael Keating 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 124 KB

Rituximab in combination with high-dose

✍ Castro, J E; James, D F; Sandoval-Sus, J D; Jain, S; Bole, J; Rassenti, L; Kipps 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 412 KB

Rituximab in combination with high-dose

✍ Rassenti, L; Kipps, T J; Castro, J E; James, D F; Sandoval-Sus, J D; Jain, S; Bo 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 56 KB